ARCHIVES

Leter: Payers Must Determine Appropriate Therapies

This article is from The Cancer Letter archive.

Vol. 22 No. 29 | July 19, 1996

Download PDF Visit The Full Archive

Related Articles

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

FDA Discloses Avastin Regulatory History.

December 14, 2007

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

Proposed Regulations for Center Grants In Federal Register

October 29, 1976